Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Charles Fracchia selected for DARPA ISAT Study Group

    May 25, 2021, 13:16 PM by
    Full story
  • VERICHEM LABORATORIES OFFERS LIQUID STABLE, NIST TRACEABLE, COMBINED CHOLESTEROL/URIC ACID STANDARD REFERENCE KIT

    May 25, 2021, 13:16 PM by
    The liquid stable and ready-to-use MATRIX PLUS™ Cholesterol Reference Kit, containing known concentrations of both Cholesterol and Uric Acid and expressly designed to support overall system QC and CLIA compliance, is now available from VERICHEM LABORATORIES.
    Full story
  • The Jewish General Hospital and the CIUSSS du Centre-Ouest-de-l’Ile-de-Montréal Partner with MDClone to Deliver Better Data-Driven Care for Patients

    May 25, 2021, 13:16 PM by
    Full story
  • US Orthopedic Alliance Selects 2bPrecise to Accelerate Precision Medicine Program

    May 25, 2021, 13:16 PM by
    US Orthopedic Alliance (USOA) selected 2bPrecise to provide its precision medicine platform to USOA’s network of more than 100 orthopedic surgeons.
    Full story
  • Sensyne Health Signs Strategic Research Agreement with the Colorado Center for Personalized Medicine

    May 25, 2021, 13:16 PM by
    Full story
  • Pronalyse's Comprehensive Biosimilar Analysis Solutions Support Your Drug Discovery

    May 25, 2021, 13:16 PM by
    Full story
  • Vizgen Launches Data Release Program, Shares Spatial Genomics Mouse Brain Map

    May 20, 2021, 01:00 AM by User Not Found
    Bio-IT World | Vizgen has released its first freely-available dataset as part of its newly-launched Vizgen Data Release Program. The Vizgen MERFISH Mouse Brain Receptor Map is an open-source spatial genomics dataset containing the exact position of transcripts from 483 genes across three full coronal slices with three biological replicates for each slice.
    Full story
  • Mount Sinai Moving Genomics Into Clinical Care

    May 19, 2021, 01:00 AM by User Not Found
    Bio-IT World | The Institute for Genomic Health at Mount Sinai Health System is launching pilot programs in the clinic based on discoveries from genomic research to evaluate their real-world utility. Where genomics data proves useful, the necessary infrastructure then gets built in terms of educating medical professionals and creating navigational paths for patients to bring that information to bear in clinical decision-making.
    Full story
  • Five-Year Plan: The Changing Landscape of Science, Storage

    May 18, 2021, 01:00 AM by User Not Found
    Bio-IT World | Glenn Lockwood serves as a storage architect at the National Energy Research Scientific Computing Center based at Lawrence Berkeley National Laboratory. In this role, he’s had a front-row seat to the changing demands of science on storage.
    Full story
  • AI and the Lab of the Future

    May 14, 2021, 11:41 AM by User Not Found
    Bio-IT World | The laboratory of the future does not look at all like what we think of today but will instead be a network of physical and virtual spaces, spanning the entire lifecycle of therapeutic products. Robot-guided molecular and cellular biology labs test predictions of new chemicals generated in the cloud. Biomarkers derived from organs on a chip and federated global clinical trials yield patient-precise clinician reports. Sensors monitor compliance and collect troves of data over time. In fact, all of these technologies are here today, but the laboratory of the future will learn to connect them into constellations of discovery.
    Full story
  • Tailocins Play Starring Role In Atomic-Level Horror Show

    May 13, 2021, 01:00 AM by User Not Found
    Bio-IT World | Large protein nanomachines produced by bacteria to selectively annihilate other members of their microbial community could one day be weaponized for wiping out undesirable inhabitants of the human microbiome known to cause ill health and disease.
    Full story
  • St Jude Releases Early Data on Asymptomatic Cases Among Vaccinated Healthcare Workers

    May 12, 2021, 01:00 AM by User Not Found
    Bio-IT World | In a research letter published last week in JAMA, St Jude Children’s Research Hospital researchers reported early findings tracking asymptomatic COVID-19 among vaccinated healthcare workers. The findings will inform both individual vaccination plans as well as institutional screening and testing programs.
    Full story
  • Value Of Drug Repurposing May Lie In Host-Directed Therapies

    May 10, 2021, 01:00 AM by User Not Found
    Bio-IT World | The University of California, San Francisco’s (UCSF) Quantitative Biosciences Institute (QBI) spearheaded a six-nation collaborative around COVID-19 that now has 26 potential treatments in clinical trials.
    Full story
  • Human Biospecimen Procurement Should Be More User Friendly

    May 6, 2021, 01:00 AM by User Not Found
    Bio-IT WorldWhile the vast majority of R&D procurement may never be as easy as point-and-click, we can look to consumer marketplaces for ideas on how to improve the overall life science buying experience.
    Full story
  • Could Death Receptor 5 Antibodies Make A Comeback?

    May 4, 2021, 01:00 AM by User Not Found
    Bio-IT World | Big pharma has invested billions of dollars in developing antibodies targeting death receptor 5 (DR5) over the years in hopes of improving the survival of patients with cancer. While promising when tested in mice in the lab, they invariably failed to show efficacy during phase 2 clinical studies. But researchers at the University of Virginia now have a new theory that could revive them.
    Full story
  • Sequencing Project for Developmental Differences, New Data Management Tools, Hyperscale Storage, More

    May 3, 2021, 01:00 AM by User Not Found
    Bio-IT World | NIH grant tackles COVID-19 disparities, St. Jude launches historic expansion, Illumina all in on African Pathogen Genomics Initiative, and new platforms and services to ease drug and vaccine development. Plus: new storage from VAST Data, and new solutions for tracking research papers and patents.
    Full story
  • Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management

    Apr 29, 2021, 01:00 AM by User Not Found
    Bio-IT World | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.
    Full story
  • Understanding Proteins With Natural Language Processing

    Apr 28, 2021, 01:00 AM by User Not Found
    Bio-IT World | New research from the departments of chemistry and physics at Cambridge University has just helped demonstrate the potential of natural language processing (NLP) for understanding biomolecular condensates.
    Full story
  • ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers

    Apr 27, 2021, 14:09 PM by
    The collaboration will improve visibility and reporting of cell and gene therapy manufacturing through a pre-integrated data solution
    Full story
  • News Update: MedAI Integrates AIDD Platform, CADD Platform, and Experimental Validation Platform for Drug Discovery

    Apr 27, 2021, 14:08 PM by
    Earlier this month, MedAI announces that it has integrated its three AI-powered drug discovery platforms so as to increase drug candidate efficacy and safety throughout the preclinical research. Previously, the company has released AIDD Platform, CADD Platform, and Experimental Validation Platform, which consist of proprietary hardware, biological, molecular and digital technologies.
    Full story
  • «
  • 171 (current)
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy